Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns naming Bríd Murphy .
Filed returns
34
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| May–Aug 2026 | Irish Cancer Society | Health | National Cancer Strategy (Public policy or programme) | 14 | On lobbying.ie |
| May–Aug 2026 | Irish Cancer Society | Health | Pre-Budget Submission (Matters involving public funds) | 15 | On lobbying.ie |
| May–Aug 2026 | Pinnacle Public Affairs Ltd | Health | Budget submission for the Irish Cardiac Society (Matters involving public funds) | 5 | On lobbying.ie |
| May–Aug 2026 | Pinnacle Public Affairs Ltd | Health | Budget submission for Dental Health Foundation Ireland (Matters involving public funds) | 7 | On lobbying.ie |
| May–Aug 2026 | Irish Cancer Society | Health | Lung Health Check (Public policy or programme) | 3 | On lobbying.ie |
| May–Aug 2026 | NCBI | Health | Assistive technology for people who are blind or vision impaired. (Public policy or programme) | 7 | On lobbying.ie |
| May–Aug 2026 | Irish Institute of Clinical Measurement Physiology (IICMP) | Health | Correspondence to the Minister for Health regarding oversight of Clinical Measurement Physiology, including HSE involvement in programme approval and qualification recognition, the absence of a designated competent… (Public policy or programme) | 6 | On lobbying.ie |
| May–Aug 2026 | Irish Platform for Patients' Organisations, Science and Industry | Health | Early access to medicines - IPPOSI wrote to the Minister for Health setting out the organisation's position on early access to medicines. The letter was also forwarded in parallel to key ministerial advisers, a relevant… (Public policy or programme) | 5 | On lobbying.ie |
| May–Aug 2026 | Pfizer | Health | Expansion of the National Immunisation Programme to include RSV vaccination for older adults (Public policy or programme) | 16 | On lobbying.ie |
| Jan–Apr 2026 | FIPRA International SRL | Health | Sexual Health Policy in Ireland (Public policy or programme) | 11 | On lobbying.ie |
| Jan–Apr 2026 | Pender & Associates Ltd | Health | Invitation to Minister to attend IDA event (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2026 | Vulcan Consulting Limited | Health | Sexual Health Policy in Ireland (Public policy or programme) | 25 | On lobbying.ie |
| Jan–Apr 2026 | Irish Cancer Society | Health | National Cancer Strategy (Public policy or programme) | 3 | On lobbying.ie |
| Jan–Apr 2026 | Rare Diseases Ireland | Health | Rare Diseases at the EU Presidency (Public policy or programme) | 4 | On lobbying.ie |
| Sep–Dec 2025 | Bayer Limited | Health | Roundtable hosted by the German Chamber of Commerce in Ireland to discuss competitiveness of the sector in Ireland and Europe. (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2025 | Rare Diseases Ireland | Health | Seeking to highlight rare diseases during Ireland's EU Presidency in 2026 with an official event during the presidency (Public policy or programme) | 4 | On lobbying.ie |
| Sep–Dec 2025 | Irish Cancer Society | Health | Expansion of QUIT services (Legislation) | 16 | On lobbying.ie |
| Sep–Dec 2025 | Rockwood Consulting ULC | Health | Sought meetings to brief DPOs on Veonet's service offering and the development of a national eyecare strategy (Public policy or programme) | 24 | On lobbying.ie |
| Sep–Dec 2025 | COPD Support Ireland | Health | We organised a lunch with Oireachtas members in the members restaurant of Leinster House to discuss the results of our membership survey, vaccinations for patients, integrated model of care, Sustainable funding for… (Public policy or programme) | 12 | On lobbying.ie |
| Sep–Dec 2025 | Irish Cancer Society | Health | Oireachtas Committee on Health (Public policy or programme) | 11 | On lobbying.ie |
| Sep–Dec 2025 | Irish Cancer Society | Health | HPV Vaccination Programme (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2025 | Irish Cancer Society | Health | Budget 2026 (Matters involving public funds) | 9 | On lobbying.ie |
| Sep–Dec 2025 | Irish Cancer Society | Health | Nicotine product regulation (Legislation) | 16 | On lobbying.ie |
| May–Aug 2025 | AstraZeneca Pharmaceuticals (Ireland) DAC | Health | Sharing a Proposal for an Early Access Programme for Innovative Oncology Medicines Budget 2026 (Matters involving public funds) | 27 | On lobbying.ie |
| May–Aug 2025 | GSK | Health | Vaccination policy (Public policy or programme) | 20 | On lobbying.ie |
| May–Aug 2025 | Irish Cancer Society | Health | National advocacy programme (Public policy or programme) | 2 | On lobbying.ie |
| May–Aug 2025 | NCBI | Health | Aids and appliances for visual impairment (Public policy or programme) | 4 | On lobbying.ie |
| May–Aug 2025 | Pinnacle Public Affairs Ltd | Health | To engage with key stakeholders on funding for oral health prevention schemes in Budget 2026 (Matters involving public funds) | 10 | On lobbying.ie |
| May–Aug 2025 | Lir Communications Ltd | Health | Letter to request meeting to discuss the location of the National Advanced AHR Centre in Cork. (Public policy or programme) | 4 | On lobbying.ie |
| May–Aug 2025 | Lir Communications Ltd | Health | Letter to request meeting to discuss the location of the National Advanced AHR Centre in Cork. (Public policy or programme) | 4 | On lobbying.ie |
| Jan–Apr 2024 | BioMarin International Limited | Health | Rare disease policy and access to treatments in Ireland and EU (Legislation) | 29 | On lobbying.ie |
| Jan–Apr 2023 | Autism Spectrum Information, Advice and Meeting Point Ltd, Trading as AsIAm | Health | To mark World Autism Month, AsIAm ran the Same Chance Campaign. This campaign aimed to highlight the broad range of barriers which Autistic people experience in Irish society and seek improved support and public… (Public policy or programme) | 27 | On lobbying.ie |
| Jan–Apr 2023 | Vulcan Consulting Limited | Health | Rare Disease Policy in Ireland (Public policy or programme) | 6 | On lobbying.ie |
| Sep–Dec 2022 | Novo Nordisk Limited | Health | To discuss the importance of an innovative ecosystem, including access and reimbursement environment, for a successful life science industry in Ireland to secure our place as a leading life sciences nation for the… (Public policy or programme) | 3 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 34 | 100.0% |